bioRxivBiophysicsPreprint
Nanopores reveal the stoichiometry of single oligo-adenylates produced by type III CRISPR-Cas
D. Fuentenebro-Navas, J. A. Steens, C. De Lannoy, B. Noordijk, D. de Ridder, R. H. J. Staals, S. Schmid
Abstract
Cyclic oligoadenylates (cOAs) are small second messenger molecules produced by the type III CRISPR-Cas system as part of the prokaryotic immune response. The role of cOAs is to allosterically activate downstream effector proteins that induce dormancy or cell death, and thus abort viral spread through the population. Interestingly, different type III systems have been reported to utilize different cOA stoichiometries (with 3 to 6 adenylate monophosphates). However, so far, their characterization has only been possible in bulk and with sophisticated equipment, while a portable assay with single-molecule resolution has been lacking. Here, we demonstrate the label-free detection of single cOA molecules using a simple protein nanopore assay. It sensitively identifies the stoichiometry of individual cOA molecules and their mixtures from synthetic and enzymatic origin. To achieve this, we trained a convolutional neural network (CNN) and validated it with a series of experiments on mono- and polydisperse cOA samples. Ultimately, we determined the stoichiometric composition of cOAs produced enzymatically by the CRISPR type III-A and III-B variants of Thermus thermophilus. Interestingly, both variants produce cOAs of nearly identical composition, and we discuss the biological implications of this finding. The presented nanopore-CNN workflow with single-cOA resolution can be adapted to many other signaling molecules (including eukaryotic ones), and it may be integrated into portable handheld devices with potential point-of-care applications.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cyclic tetra-adenylate triggers Cap1 membrane pore opening and depolarization during the type III CRISPR immune response
Puja Majumder, Clare W. Cahir, … Luciano A. Marraffini·bioRxiv·Nov 13, 2025
- Structure and mechanism of a Type III CRISPR defence DNA nuclease activated by cyclic oligoadenylate
S. A. McMahon, W. Zhu, … T. M. Gloster·bioRxiv·Sep 26, 2019
- Tetramerisation of the CRISPR ring nuclease Csx3 facilitates cyclic oligoadenylate cleavage
S. Graham, S. Grüschow, … J. S. Athukoralage·bioRxiv·Apr 28, 2020
- Molecular basis of stepwise cyclic tetra-adenylate cleavage by the type III CRISPR ring nuclease Crn1/Sso2081
Liyang Du, Danping Zhang, … Zhonghui Lin·Nucleic Acids ResearchPeer-reviewed·Feb 4, 2023
- Ring nucleases deactivate Type III CRISPR ribonucleases by degrading cyclic oligoadenylate
J. S. Athukoralage, C. Rouillon, … M. F. White·bioRxiv·Jul 30, 2018
- The dynamic interplay of host and viral enzymes in type III CRISPR-mediated cyclic nucleotide signalling
J. S. Athukoralage, S. Grüschow, … M. F. White·bioRxiv·Feb 12, 2020